Identifying SNP targeted pathways in partial epilepsies with genome-wide association study data.
B Bakir-Gungor1, B Baykan, S Ugur İseri
1Department of Genetics and Bioinformatics, Faculty of Arts and Sciences, Bahcesehir University, Ciragan Cad. Osmanpasa Mektebi Sok., No.: 4, 34353, Besiktas, Istanbul, Turkey. burcu.gungor@bahcesehir.edu.tr
Epilepsy Research
|March 19, 2013
Summary
Identifying key molecular pathways is crucial for understanding complex diseases like partial epilepsy. This study reveals 30 overrepresented pathways, offering a new approach to epilepsy genetic research.
Area of Science:
- Genetics
- Systems Biology
- Neuroscience
Background:
- Partial epilepsy is a complex disease influenced by multiple genetic and molecular factors.
- Genome-wide association studies (GWAS) have shown modest effects of common genetic variations in partial epilepsy.
- Understanding disease-related pathways is critical for elucidating epilepsy mechanisms.
Purpose of the Study:
- To identify disease-related pathways for partial epilepsy using a novel methodology.
- To investigate the role of multiple genetic and molecular factors in epilepsy development.
Main Methods:
- Developed a novel methodology combining genetic association evidence with biochemical pathways, protein-protein interaction networks, and single nucleotide polymorphism (SNP) functional information.
- Applied this methodology to a large dataset of 3445 cases and 6935 controls of European ancestry for partial epilepsy.
Main Results:
- Identified 30 significantly overrepresented pathways (corrected p-values < 10^-12) associated with partial epilepsy.
- Key pathways include complement and coagulation cascades, cell cycle, focal adhesion, JAK-STAT signaling, and MAPK signaling.
- Demonstrated that different factors impact distinct pathway components, illustrated using the complement and coagulation cascades pathway.
Conclusions:
- Traditional GWAS have limitations in detecting epilepsy-associated genetic variations due to heterogeneity.
- Integrating functional SNP effects, protein-protein interactions, and pathway analysis into GWAS is more effective for identifying key molecular pathways in epilepsy.
- This pathway-centric approach advances the understanding of the complex genetic architecture of epilepsies.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...


